AWP Reform Must Wait For Congressional Study, Oncologists Say
Executive Summary
CMS cannot implement reforms to the AWP-based reimbursement system for Medicare Part B drugs before the General Accounting Office has completed a study requested by Congress, the American Society of Clinical Oncology says
You may also be interested in...
AWP Reform Debate Continues; U.S. Oncology Says Cut Will Hit Profits In ‘05
U.S. Oncology expects that the transition from AWP-based reimbursement to ASP-based reimbursement will reduce Medicare payments to oncologists by approximately 8% in 2005
AWP Reform Debate Continues; U.S. Oncology Says Cut Will Hit Profits In ‘05
U.S. Oncology expects that the transition from AWP-based reimbursement to ASP-based reimbursement will reduce Medicare payments to oncologists by approximately 8% in 2005
CMS Expected To Delay AWP Regulation; Medicare Conferees Want Credit
The Centers for Medicare & Medicaid Services is expected to hold off on issuing a final regulation reforming the AWP reimbursement methodology to allow Medicare conferees the chance to complete work on the issue